{
    "title": "Takeda Pharma gets US FDA approval for rare blood disorder therapy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12731923/Takeda-Pharma-gets-FDA-approval-rare-blood-disorder-therapy.html",
    "date": "2023-11-09",
    "keywords": [
        "blood",
        "drug",
        "vaibhav",
        "sadhamta",
        "therapy",
        "disorder",
        "treatment",
        "ttp",
        "clotting",
        "pratik",
        "jain",
        "food",
        "administration",
        "adult",
        "thrombocytopenic",
        "purpura",
        "chronic",
        "body",
        "anemia",
        "platelet",
        "fda",
        "side",
        "headache",
        "pain",
        "nausea",
        "respiratory",
        "infection",
        "dizziness",
        "health",
        "decision",
        "latestage",
        "study",
        "incidence",
        "thrombocytopenia",
        "symptom",
        "disease",
        "level",
        "care",
        "takeda",
        "adzynma",
        "december",
        "pricing",
        "time",
        "president",
        "business",
        "unit",
        "julie",
        "kim",
        "tak755",
        "deficient",
        "protein",
        "site",
        "injury",
        "offlabel",
        "use",
        "cancer",
        "rituxan",
        "condition",
        "reporting",
        "khushi",
        "mandowara",
        "bengaluru",
        "editing",
        "dasgupta",
        "subhranshu",
        "sahu"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}